Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details)

v3.25.0.1
Discontinued Operations - Reconciliation of Loss from Discontinued Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
Results of operations for discontinued operations          
Research and development $ 1,877 $ 1,535 $ 3,182 $ 3,141  
Loss from discontinued operations   (3,723)   (4,395)  
iBio CDMO, LLC | Discontinued Operations          
Results of operations for discontinued operations          
General and administrative   307   671  
Fixed asset impairments   3,100   3,100 $ 3,100
Gain on sale of fixed assets       (50) $ 4,800
Total operating expenses   3,407   3,721  
Interest expense - term note payable   (316)   (674)  
Total other expenses   (316)   (674)  
Loss from discontinued operations   $ (3,723)   $ (4,395)